The Morphologic and Immunohistochemical Spectrum of Papillary Renal Cell Carcinoma Study Including 132 Cases With Pure Type 1 and Type 2 Morphology As Well As Tumors With Overlapping Features

被引:45
作者
Chevarie-Davis, Myriam [1 ]
Riazalhosseini, Yasser [2 ,4 ,5 ]
Arseneault, Madeleine [2 ,4 ,5 ]
Aprikian, Armen [3 ]
Kassouf, Wassim [3 ]
Tanguay, Simon [3 ]
Latour, Mathieu [6 ]
Brimo, Fadi [1 ]
机构
[1] McGill Univ, Dept Pathol, Montreal, PQ H3A 2T5, Canada
[2] McGill Univ, Dept Human Genet, Montreal, PQ H3A 2T5, Canada
[3] McGill Univ, Dept Urol, Montreal, PQ H3A 2T5, Canada
[4] McGill Univ, Montreal, PQ H3A 2T5, Canada
[5] Genome Quebec Innovat Ctr, Quebec City, PQ, Canada
[6] Univ Montreal, Montreal, PQ H3C 3J7, Canada
关键词
papillary; renal cell carcinoma; nucleoli; immunohistochemistry; stage; SNP array; CLINICOPATHOLOGICAL CHARACTERISTICS; DIFFERENTIAL EXPRESSION; HISTOLOGICAL SUBTYPES; PROGNOSTIC IMPACT; TYPE-1; CLASSIFICATION; SURVIVAL; TUMORS; GRADE;
D O I
10.1097/PAS.0000000000000247
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Papillary renal cell carcinomas (pRCC) are classically divided into type 1 and 2 tumors. However, many cases do not fulfill all the criteria for either type. We describe the clinical, morphologic, and immunohistochemical (IHC) features of 132 pRCCs to better characterize the frequency and nature of tumors with overlapping features. Cases were reviewed and classified; IHC evaluation of CK7, EMA, TopoII alpha, napsin A, and AMACR was performed on 95 cases. The frequencies of type 1, type 2, and "overlapping" pRCC were 25%, 28%, and 47%, respectively. The 2 categories of "overlapping" tumors were: (1) cases with bland cuboidal cells but no basophilic cytoplasm (type A); and (2) cases with predominantly type 1 histology admixed with areas showing prominent nucleoli (type B). The pathologic stage of "overlapping" cases showed concordance with type 1 tumors. Using the 2 discriminatory markers (CK7, EMA), "type A" cases were similar to type 1. Although the high-nuclear grade areas of "type B" tumors showed some staining differences from their low-nuclear grade counterpart, their IHC profile was closer to type 1. Single nucleotide polymorphism array results, although preliminary and restricted to only 9 cases (3 with overlapping features), also seemed to confirm those findings. In conclusion, we demonstrate that variations in cytoplasmic quality and/or presence of high-grade nuclei in tumors otherwise displaying features of type 1 pRCCs are similar in stage and IHC profile those with classic type 1 histology, suggesting that their spectrum might be wider than originally described.
引用
收藏
页码:887 / 894
页数:8
相关论文
共 23 条
  • [1] Expanding the morphologic spectrum of chromophobe renal cell carcinoma: A study of 8 cases with papillary architecture
    Michalova, Kvetoslava
    Tretiakova, Maria
    Pivovarcikova, Kristyna
    Alaghehbandan, Reza
    Perez Montiel, Delia
    Ulamec, Monika
    Osunkoya, Adeboye
    Trpkov, Kiril
    Yuan, Gao
    Grossmann, Petr
    Sperga, Maris
    Ferak, Ivan
    Rogala, Joanna
    Mareckova, Jana
    Pitra, Tomas
    Kolar, Jiri
    Michal, Michal
    Hes, Ondrej
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2020, 44
  • [2] Type 1 papillary renal cell carcinoma: differentiation from Type 2 papillary RCC on multiphasic MDCT
    Young, Jonathan R.
    Coy, Heidi
    Douek, Michael
    Lo, Pechin
    Sayre, James
    Pantuck, Allan J.
    Raman, Steven S.
    ABDOMINAL RADIOLOGY, 2017, 42 (07) : 1911 - 1918
  • [3] Cytogenetic features, clinical significance and prognostic impact of type 1 and type 2 papillary renal cell carcinoma
    Antonelli, Alessandro
    Tardanico, Regina
    Balzarini, Piera
    Arrighi, Nicola
    Perucchini, Laura
    Zanotelli, Tiziano
    Cozzoli, Alberto
    Zani, Danilo
    Cunico, Sergio Cosciani
    Simeone, Claudio
    CANCER GENETICS AND CYTOGENETICS, 2010, 199 (02) : 128 - 133
  • [4] Morphologic subtyping as a prognostic predictor for survival in papillary renal cell carcinoma: Type 1 vs. type 2
    Wong, Emily C. L.
    Di Lena, Richard
    Breau, Rodney H.
    Pouliot, Frederic
    Finelli, Antonio
    Lavallee, Luke T.
    So, Alan
    Tanguay, Simon
    Fairey, Adrian
    Rendon, Ricardo
    Richard, Patrick O.
    Lattouf, Jean-Baptiste
    Kawakami, Jun
    Mallick, Ranjeeta
    Kapoor, Anil
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2019, 37 (10) : 721 - 726
  • [5] Comparison of clinicopathologic parameters and oncologic outcomes between type 1 and type 2 papillary renal cell carcinoma
    Le, Xiang
    Wang, Xiang-Bo
    Zhao, Hao
    Chen, Ren-Fu
    Ge, Peng
    BMC UROLOGY, 2020, 20 (01)
  • [6] Presence and extent of histological tumour necrosis is an adverse prognostic factor in papillary type 1 but not in papillary type 2 renal cell carcinoma
    Pichler, Martin
    Hutterer, Georg C.
    Chromecki, Thomas F.
    Pummer, Karl
    Mannweiler, Sebastian
    Zigeuner, Richard
    HISTOPATHOLOGY, 2013, 62 (02) : 219 - 228
  • [7] Cytogenetic and Molecular Tumor Profiling for Type 1 and Type 2 Papillary Renal Cell Carcinoma
    Klatte, Tobias
    Pantuck, Allan J.
    Said, Jonathan W.
    Seligson, David B.
    Rao, Nagesh P.
    LaRochelle, Jeffrey C.
    Shuch, Brian
    Zisman, Amnon
    Kabbinavar, Fairooz F.
    Belldegrun, Arie S.
    CLINICAL CANCER RESEARCH, 2009, 15 (04) : 1162 - 1169
  • [8] Cytomorphologic Comparison of Type 1 and Type 2 Papillary Renal Cell Carcinoma: A Retrospective Analysis of 28 Cases
    Magers, Martin J.
    Perrino, Carmen M.
    Cramer, Harvey M.
    Wu, Howard H.
    CANCER CYTOPATHOLOGY, 2019, 127 (06) : 370 - 376
  • [9] Spindle Cell Thymomas (WHO Type A) With Prominent Papillary and Pseudopapillary Features: A Clinicopathologic and Immunohistochemical Study of 10 Cases
    Kalhor, Neda
    Suster, Saul
    Moran, Cesar A.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2011, 35 (03) : 372 - 377
  • [10] The clinicopathologic and molecular features, and treatment outcome of fumarate hydratase-deficient renal cell carcinoma: a retrospective comparison with type 2 papillary renal cell carcinoma
    Bai, Junjie
    Li, Xiaoyan
    Wen, Yahui
    Lu, Qing
    Chen, Ru
    Liu, Rong
    Tong, Shangguan
    Ye, Yushi
    Lin, Jun
    Cai, Weizhong
    Kang, Deyong
    Chen, Jianhui
    AGING-US, 2024, 16 (04): : 3631 - 3646